Apollomics Inc. - Warrant Share · KYG0411D1152 · APLMW (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of Apollomics Inc. - Warrant

No Price

01.05.2026 19:04

Current Prices from Apollomics Inc. - Warrant

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	APLMW	USD	01.05.2026 19:04	0,02 USD	0,002 USD +10,18 %
IEX	APLMW	USD	30.04.2026 13:30	0,02 USD	-

Share Float & Liquidity

Free Float 1,51 %

Shares Float 223,46 M

Shares Outstanding 14,78 B

Company Profile for Apollomics Inc. - Warrant Share

Apollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company was founded by Liang Yu Guo and Sanjeev Redkar in 2015 and is headquartered in Foster City, CA.

Company Data

Name Apollomics Inc. - Warrant

Company Apollomics, Inc.

Symbol APLMW

Website http://www.apollomicsinc.com

Primary Exchange

NASDAQ

ISIN KYG0411D1152

Asset Class Share

Sector Financial Services

Industry Financial - Conglomerates

CEO Guo-Liang Yu

Market Capitalization 272 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address , Foster City

IPO Date 2023-03-30

Ticker Symbols

Name	Symbol
NASDAQ	APLMW

More Shares

Investors who hold Apollomics Inc. - Warrant also have the following shares in their portfolio:

NORDLB GELDM.FRN 05/17 Bond

RESIDENTIAL MORTGAGE SECURITIES 10 PLC CLASS 'B' MTG BCKD FRN 10/08/39 (REG S) Bond